University Of Stellenbosch
Clinical trials sponsored by University Of Stellenbosch, explained in plain language.
-
Could a common diabetes drug shield the brain in HIV patients?
Disease control CompletedThis pilot study tested whether metformin, a standard diabetes drug, can reduce blood vessel damage and inflammation in the brain for people living with HIV who also have metabolic syndrome. Thirty participants received metformin for 12 weeks, and researchers measured changes in …
Phase: PHASE2 • Sponsor: University of Stellenbosch • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
ICU muscle loss: amino acid cocktail and cycling tested
Knowledge-focused CompletedThis study tested whether giving extra amino acids through a vein and having patients cycle while in bed could prevent muscle loss during the first week in the ICU. Half of the 50 participants received the extra amino acids and cycling, while the other half received standard care…
Phase: NA • Sponsor: University of Stellenbosch • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC